Tizanidine Hcl Tablet
Product Images NDC 80425-0022

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine Hcl (NDC 80425-0022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1

Figure 1
FDA Label Image

Figure 2

Figure 2
FDA Label Image

Figure 3

Figure 3
The text describes the improvement in Ashworth Score at the end of titration and maintenance stages of a study. The mean dose used was 26.8mg. The endpoint was observed through the "Last Observation Carried Forward" method.*
FDA Label Image

Structure

Structure
FDA Label Image

Tizanidine HCl 4mg Cap Qty 90 Ndc 80425 0022

Tizanidine HCl 4mg Cap Qty 90 Ndc 80425 0022
FDA Label Image

Tizanidine HCl 4mg Tab Qty 60 Ndc 80425 0022

Tizanidine HCl 4mg Tab Qty 60 Ndc 80425 0022
This appears to be a label from a medication packaging. The medication is Tizanidine HCl 2mg tablets and the package contains 60 tablets. The name of the company or individual who packed the medication is not clear due to the formatting, so it is not-available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.